Login / Signup

Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite.

Raffaela S BergerChristian J WachsmuthMagdalena C WaldhierKathrin Renner-SattlerSimone ThomasAnuhar ChaturvediHans-Helmut NillerElisabeth BumesPeter HauMartin ProescholdtWolfram GronwaldMichael HeuserMarina KreutzPeter J OefnerKatja Dettmer
Published in: Cancers (2021)
In recent years, onco-metabolites like D-2-hydroxyglutarate, which is produced in isocitrate dehydrogenase-mutated tumors, have gained increasing interest. Here, we report a metabolite in human specimens that is closely related to 2-hydroxyglutarate: the intramolecular ester of 2-hydroxyglutarate, 2-hydroxyglutarate-γ-lactone. Using 13C5-L-glutamine tracer analysis, we showed that 2-hydroxyglutarate is the endogenous precursor of 2-hydroxyglutarate-lactone and that there is a high exchange between these two metabolites. Lactone formation does not depend on mutated isocitrate dehydrogenase, but its formation is most probably linked to transport processes across the cell membrane and favored at low environmental pH. Furthermore, human macrophages showed not only striking differences in uptake of 2-hydroxyglutarate and its lactone but also in the enantiospecific hydrolysis of the latter. Consequently, 2-hydroxyglutarate-lactone may play a critical role in the modulation of the tumor microenvironment.
Keyphrases
  • endothelial cells
  • risk assessment
  • induced pluripotent stem cells
  • pluripotent stem cells
  • wild type
  • positron emission tomography
  • pet imaging
  • pet ct
  • energy transfer
  • life cycle